Behind China Peptide Source
Learn how our dual-hub model connects research laboratories directly to primary manufacturing while maintaining local domestic fulfillment in the United States.
Learn how our dual-hub model connects research laboratories directly to primary manufacturing while maintaining local domestic fulfillment in the United States.
Established in 2020, China Peptide Source was built to solve supply chain inefficiencies within the peptide research industry. Traditional distribution channels often involve multiple intermediaries, leading to markups, extended delivery windows, and inconsistent batch traceability.
We streamline this process by pairing primary factory synthesis in Shenzhen, China with local warehouse operations in San Francisco, CA. This dual-presence allows us to combine direct manufacturing oversight with fast domestic dispatch across North America.
Our commitment remains straightforward: provide analytical transparency through independent laboratory verification, maintain robust stock levels, and deliver responsive institutional support for every order.
View Contact Details & Hubs
Direct integration with our Shenzhen synthesis facilities ensures rigorous batch oversight and consistent production standards.
Every batch is subjected to external HPLC and Mass Spectrometry testing to ensure documentation accuracy for research compliance.
Our San Francisco fulfillment center maintains ready-to-ship inventory for rapid domestic distribution without customs delays.
Dedicated client care representatives assist with technical inquiries, bulk inquiries, and batch paperwork around the clock.
Serving Research Partners
San Francisco & Shenzhen
Tested Batch Quality and Third-party COA
Fast Fulfillment Capabilities
View our complete index of research compounds, batch documentation, and product availability.
Browse Product Catalog